<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02178319</url>
  </required_header>
  <id_info>
    <org_study_id>portal hypertension</org_study_id>
    <nct_id>NCT02178319</nct_id>
  </id_info>
  <brief_title>Laparoscopic Versus Open Devascularization for Portal Hypertension, a Randomized Controlled Trial</brief_title>
  <official_title>Randomized Clinical Trial Comparing Laparoscopic and Open Esophagogastric Devascularization and Splenectomy for Portal Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital of Xi'an Jiaotong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Second Affiliated Hospital of Xi'an Jiaotong University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Many patients with portal hypertension require surgical treatment each year,and Hassab's
      operation, or esophagogastric devascularization and splenectomy, is an elective procedure. In
      recent years,laparoscopic esophagogastric devascularization and splenectomy has been used to
      treat portal hypertension. However, the potential benefits remain to be demonstrated in the
      context of a randomized trial. In this study, 120 patients will randomize equally receiving
      laparoscopic or open esophagogastric devascularization and splenectomy. Inclusion criteria
      included: platelet count &lt; 50×109/ml, esophageal and gastric varices revealed, agreeing the
      informed consent. PerioperativeOutcomes are: technical success, blood loose and infusion
      during the operation, recurrent varicose veins on gastroscopy examination, patterns of reflux
      on duplex ultrasound examination, complications, platelet and liver function variation,
      length of hospital stay. Follow-up will last 5 years, and gastroscopy and ultrasonic will
      perform at 3 months, 1 year, 3 years, and 5 years. Further more, this study was proved by the
      ethical committee of second hospital of Xi'an jiaotong university.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>recurrence</measure>
    <time_frame>5 years</time_frame>
    <description>gastroesophageal varices recurrence rate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>operation time</measure>
    <time_frame>1 day</time_frame>
    <description>Duration of surgical procedure</description>
  </secondary_outcome>
  <other_outcome>
    <measure>blood loss during surgical procedure</measure>
    <time_frame>1 day</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>blood transfusion during surgical procedure</measure>
    <time_frame>1 day</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Number of Participants with Serious and Non-Serious Adverse Events</measure>
    <time_frame>4 weeks</time_frame>
    <description>record all kind of postoperative complications in each patient</description>
  </other_outcome>
  <other_outcome>
    <measure>rebleeding</measure>
    <time_frame>1 day</time_frame>
    <description>record rebleeding time in each bleeding patient</description>
  </other_outcome>
  <other_outcome>
    <measure>cost of hospitalization</measure>
    <time_frame>4 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>survival</measure>
    <time_frame>5 years</time_frame>
    <description>record the time of death and the death reason</description>
  </other_outcome>
  <other_outcome>
    <measure>length of hospital stay</measure>
    <time_frame>4 weeks</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Portal Hypertension</condition>
  <condition>Liver Cirrhosis</condition>
  <arm_group>
    <arm_group_label>open group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>the patients under go the open esophagogastric devascularization and splenectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>laparoscopic group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the patients under go the laparoscopic esophagogastric devascularization and splenectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>open surgical procedure</intervention_name>
    <description>open esophagogastric devascularization and splenectomy will perform as surgical procedure in the patients</description>
    <arm_group_label>open group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopic surgical procedure</intervention_name>
    <description>laparoscopic esophagogastric devascularization and splenectomy will perform as surgical procedure in the patients</description>
    <arm_group_label>laparoscopic group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The cause of portal hypertension was cirrhosis

          -  Platelet count &lt; 50×109/ml

          -  Esophageal and gastric varices revealed

          -  Agreeing the informed consent.

        Exclusion Criteria:

          -  Thrombosis present in portal vein preoperatively

          -  Accompany with liver cancer

          -  Operation procedure is laparoscopy converse to open

          -  Patients disagree with the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yang Liu, Doctor</last_name>
    <phone>+86-29-87679246</phone>
    <email>individualliu@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of General Surgery , Second Afﬁliated Hospita l, Xi'an Jiaotong Universi ty School of Medicine</name>
      <address>
        <city>Xi'an</city>
        <zip>710004</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yang Liu, Doctor</last_name>
      <phone>+86-29-87679246</phone>
      <email>individualliu@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 19, 2014</study_first_submitted>
  <study_first_submitted_qc>June 26, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2014</study_first_posted>
  <last_update_submitted>June 26, 2014</last_update_submitted>
  <last_update_submitted_qc>June 26, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 30, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>portal hypertension</keyword>
  <keyword>Randomized clinical trial</keyword>
  <keyword>laparoscopic</keyword>
  <keyword>open</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Hypertension, Portal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

